Crossmark

A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse

Published Online: 2021-01-06

Published Print: 2021-04

Authors

Bakhti-Suroosh, Anousheh

Towers, Eleanor Blair

Lynch, Wendy J.
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (R01DA024716)

National Institute on Drug Abuse (R01DA039093)
License Information

Text and Data Mining valid from 2021-01-06

Version of Record valid from 2021-01-06
More Information

Article History

Received: 13 August 2020

Accepted: 8 December 2020

First Online: 6 January 2021

Compliance with ethical standards

:

: The authors declare that they have no competing interests.

Document is current